Cumberland Pharma (CPIX) Tops Q4 EPS by 1c; Guides FY11 Sales
Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.04, $0.01 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
